Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Arrayit ranks 4th in web traffic among its public company peers ILMN FLDM AFFX per corporate analytics leader Owler https://www.owler.com
Lucky my friend, if you so smart try to get 1M shares and you will
see how hard to get them.I smiling all the way to the bank
This new tweet is VERY good.
Ya we going to at least 1.00 a shares rh22 buy now
Arrayit quotes $378,000 annual microarray consumables supply agreement to top genomics leader HQ in Shanghai China http://arrayit.com/Products/products.html …
Arrayit quotes $378,000 annual microarray consumables supply agreement to top genomics leader HQ in Shanghai China http://arrayit.com/Products/products.html …
THE TERM FOR 5YEARS SEE THE 8K On October 16, 2017, Rich Pharmaceuticals, Inc. (the “Company”)
executed a subscription agreement and warrant with Richard L. Chang, LLC Holdings (the “Investor”) pursuant to which the Investor purchased 333,333,333 shares of Company common stock at $.0003 per share, and warrants to purchase 333,333,333 shares of Company common stock at $.0003 per share for a five-year term. The sale of the shares and warrants was made in reliance on the exemption provided by Section 4(2) of the Securities Act of 1933, as amended (the “Securities Act”) for the offer and sale of securities not involving a public offering. The Company's reliance upon Section 4(2) of the Securities Act in issuing the securities was based upon the following factors: (a) the issuance of the securities was an isolated private transaction by the Company which did not involve a public offering; (b) there was only a one investor who was an accredited investor; (c) there were no subsequent or contemporaneous public offerings of the securities by the Company; (d) the securities were not broken down into smaller denominations; and (e) the issuance of shares was pursuant to subscription agreement and warrant negotiated directly between the Investor and the Company.
The total number of outstanding shares of common stock of the Company as of October 16, 2017 after the above described issuances is 955,027,821
The term for 5 years !!!!
On October 16, 2017, Rich Pharmaceuticals, Inc. (the “Company”) executed a subscription agreement and warrant with Richard L. Chang, LLC Holdings (the “Investor”) pursuant to which the Investor purchased 333,333,333 shares of Company common stock at $.0003 per share, and warrants to purchase 333,333,333 shares of Company common stock at $.0003 per share for a five-year term. The sale of the shares and warrants was made in reliance on the exemption provided by Section 4(2) of the Securities Act of 1933, as amended (the “Securities Act”) for the offer and sale of securities not involving a public offering. The Company's reliance upon Section 4(2) of the Securities Act in issuing the securities was based upon the following factors: (a) the issuance of the securities was an isolated private transaction by the Company which did not involve a public offering; (b) there was only a one investor who was an accredited investor; (c) there were no subsequent or contemporaneous public offerings of the securities by the Company; (d) the securities were not broken down into smaller denominations; and (e) the issuance of shares was pursuant to subscription agreement and warrant negotiated directly between the Investor and the Company.
The total number of outstanding shares of common stock of the Company as of October 16, 2017 after the above described issuances is 955,027,821
We will see my friend......$$$$$$$$
You will see a lot of GREEN soon.
Pps looking good and heading back up!
You not getting mine. I already won the lottery ticket
Arrayit offers a complete line of VIP™ genotyping platforms as well as complete laboratory and cleanroom packages for genetic and protein screening. Our extensive diagnostics product line meets the most demanding requirements of the rapidly expanding research, molecular diagnostics and commercial genotyping industries.
WE taking out the board !!!! we all going to be rich
Arrayit Corporation (ARYC) leads and empowers the genetic, research, pharmaceutical, and diagnostic communities through the discovery, development and manufacture of proprietary life science technologies and consumables for disease prevention, treatment and cure. - Powerful Science for Life™
http://www.arrayit.com/
ARYC
@Arrayit
ARYC is getting ready to be a monster :)
Arrayit Corporation
927 Thompson Place
Sunnyvale, CA 94085
USA
Phone 408-744-1331
FAX 408-744-1711
Email arrayit@arrayit.com
Web www.arrayit.com
Arrayit microarray services team completes $550,000 manufacturing run for a major biomedical research customer http://arrayit.com
Arrayit reports $123,000 microarray instrument inquiry from research leader Khon Kaen University Khon Kaen Thailand https://www.kku.ac.th/index.php?l=en
Arrayit microarray services team reports positive amplification results on diabetes research specimens for a major US research laboratory.
Arrayit reports positive progress towards audit completion by top accounting firm RRBB headquartered in Somerset NJ http://www.rrbb.com
Hi all I think everyone on here secretly believes the ARYC tweets or they wouldn't be posting on ihub, which signifies that they are interested in buying:) Just imo of course.
ARYC is on a 1 year uptrend and the fact remains, what is causing the PPS to climb is a litany of factual positive turns the company has manifested:
1. They have cured their cash-flow issues that precipitated the investor/lender crisis
2. The company has managed to grow their global sales to a constant impressive level affording the financial capacity to expand their technology based products and services
3. Because of the forward effort to repair the internal reportable financial structure, the company has put forth information, through the social network approved for said dissemination of information to the public, making themselves viewable by the investment industry. As a function of business, the world investor pool will take note and accordingly perform DD and without haste invest
4. No level of complaining or criticizing of the lack of financials at this point will neither accelerate the filing or discourage potential investors to take action
"The die is cast" when it comes to the fins; they are imminently coming sooner than later and they will confirm and add to the amazing growth of this company
I say congrats to those of us who did our DD and are standing to watch the fireworks coming...GLTA
Ten Reasons To Invest in Silicon Valley Biotech Company, Arrayit Corporation $ARYC):
1. $ARYC @Arrayit on Twitter......Trading at .01 per share and headquartered in the heart of Silicon Valley. @arrayit on Twitter and Arrayit Corporation on Facebook. The company's in the final stages of an intensive audit and is set to release financials soon.
2. Arrayit Corporation is a leading edge developer, manufacturer and marketer of next-generation life science tools and integrated systems for the large-scale analysis of genetic variation, biological function and diagnostics. Using Arrayit’s proprietary technologies, the Company provides a comprehensive line of products and services that currently serve the sequencing, genotyping, gene expression and protein analysis markets, and the Company expects to enter the market for molecular diagnostics.
3. Arrayit has earned respect as a leader in the healthcare and life sciences industries with its proven expertise in three key areas: the development and support of microarray tools and components, custom printing and analysis of microarrays for research, and the identification and development of diagnostic microarrays and tools for early detection of treatable disease states.
4. Arrayit has provided tools and services to thousands of the leading genomic research centers, pharmaceutical companies, academic institutions, clinical research organizations, government agencies and biotechnology companies worldwide.
5. The Company’s patented tools and trade secrets provide researchers around the world with the performance, throughput, cost effectiveness and flexibility necessary to perform the billions of genetic tests needed to extract valuable medical information. The Company believes this information will enable researchers to correlate genetic variation and biological function, which will enhance drug discovery, drug development and clinical research, allowing diseases to be detected earlier and permitting better choices of drugs for individual patients.
6. Estimated revenues last year of over $8 million !!
7. Sales reported at $40,000+ every day !!!
8. Low float of 696m as of 3-31-17 per OTC and no increase in float or OS since 2015
9. The company is open to shareholders visiting:
927 Thompson Place
Sunnyvale, CA 94085
USA
(Apple, Google, Linkdin, AMD, Lockheed, Yahoo, Juniper and many many more high tech companies are its close by neighbors)
10. This is NOT a P&D company. This is a stock to accumulate for generational wealth. Buying shares sub-penny currently and holding will create immense wealth. There is no reason that it should not be trading over $1 per share. There are no promotions, no paid pumping, ARYC is a real company that is working its way back to the Nasdaq.
Hi, I like to follow your informative posts can you do better and inform us in details abut The news that you getting please
any contact with the ceo you have
Arrayit products featured in 5,000+ scientific publications. https://scholar.google.com/scholar?hl=en&lr=&q=arrayit+microarray
'Full Contact Yoga wow Chapter 7?? I see alL the way GREEN ,GREEN
Lucky,wow, look at the size of the buys GREEN GREEN GREEN GREEN GREEN
With this TGGI MJ Cultivation News...
This is solid tggi news and is the prelude to the much bigger marijuana cultivation news that is coming in the near future:
BIG BIG HUGE
You correct 1000% "No dilution whatsoever!! ARYC could be the stock of the year for 2017!!"
YA you are correct DemGains !!!
$ARYC on fire The Free Nubula !!
For ARYC shareholders, a merger I believe
Look at ARYC right now :)
L2 !! wow
GREEN GREEN GREEN WHY READ !!!!!!
Ten Reasons To Invest in Silicon Valley Biotech Company, Arrayit Corporation $ARYC):
1. $ARYC @Arrayit on Twitter......Trading at .0084 per share and headquartered in the heart of Silicon Valley. @arrayit on Twitter and Arrayit Corporation on Facebook. The company's in the final stages of an intensive audit and is set to release financials soon.
2. Arrayit Corporation is a leading edge developer, manufacturer and marketer of next-generation life science tools and integrated systems for the large-scale analysis of genetic variation, biological function and diagnostics. Using Arrayit’s proprietary technologies, the Company provides a comprehensive line of products and services that currently serve the sequencing, genotyping, gene expression and protein analysis markets, and the Company expects to enter the market for molecular diagnostics.
3. Arrayit has earned respect as a leader in the healthcare and life sciences industries with its proven expertise in three key areas: the development and support of microarray tools and components, custom printing and analysis of microarrays for research, and the identification and development of diagnostic microarrays and tools for early detection of treatable disease states.
4. Arrayit has provided tools and services to thousands of the leading genomic research centers, pharmaceutical companies, academic institutions, clinical research organizations, government agencies and biotechnology companies worldwide.
5. The Company’s patented tools and trade secrets provide researchers around the world with the performance, throughput, cost effectiveness and flexibility necessary to perform the billions of genetic tests needed to extract valuable medical information. The Company believes this information will enable researchers to correlate genetic variation and biological function, which will enhance drug discovery, drug development and clinical research, allowing diseases to be detected earlier and permitting better choices of drugs for individual patients.
6. Estimated revenues last year of over $8 million !!
7. Sales reported at $40,000+ every day !!!
8. Low float of 696m as of 3-31-17 per OTC and no increase in float or OS since 2015
9. The company is open to shareholders visiting:
927 Thompson Place
Sunnyvale, CA 94085
USA
(Apple, Google, Linkdin, AMD, Lockheed, Yahoo, Juniper and many many more high tech companies are its close by neighbors)
10. This is NOT a P&D company. This is a stock to accumulate for generational wealth. Buying shares sub-penny currently and holding will create immense wealth. There is no reason that it should not be trading over $1 per share. There are no promotions, no paid pumping, ARYC is a real company that is working its way back to the Nasdaq.
Here is an example of sales from the past 3 weeks:
Arrayit reports $53,700 microarray services sale to a top research laboratory focused on genome-wide gene expression (link: http://arrayit.com/Services/services.html) arrayit.com/Services/servi…
Arrayit reports $28,800 protein microarray sale to a leading human proteomics company focusing on signaling pathways (link: http://arrayit.com/Products/Protein_Microarrays/protein_microarrays.html) arrayit.com/Products/Prote…
Arrayit reports $6,000 microarray technology RFQ from life sciences and healthcare leaders BC Bio located in China (link: http://www.hcbio.cn/#) hcbio.cn/#
Arrayit reports $40,300 microarray services sale to leading biomedical research and protein expression laboratory (link: http://arrayit.com/Services/services.html) arrayit.com/Services/servi…
Arrayit reports $10,000 microarray technology sale to next generation proteomic leader CDI Laboratories Baltimore MD (link: http://cdi-lab.com) cdi-lab.com
Arrayit reports $13,700 microarray services sale to top research lab focusing on complex regulatory protein networks
(link: http://arrayit.com)
arrayit.com
Arrayit reports $6,000 microarray technology RFQ from life sciences and healthcare leaders BC Bio located in China
(link: http://www.hcbio.cn/#)
hcbio.cn/#
Arrayit reports $40,300 microarray services sale to leading biomedical research and protein expression laboratory
(link: http://arrayit.com/Services/services.html)
arrayit.com/Services/servi…
Arrayit reports $53,700 microarray services sale to a top research laboratory focused on genome-wide gene expression
(link: http://arrayit.com/Services/services.html)
arrayit.com/Services/servi…
Arrayit reports $28,800 protein microarray sale to a leading human proteomics company focusing on signaling pathways
(link: http://arrayit.com/Products/Protein_Microarrays/protein_microarrays.html)
arrayit.com/Products/Prote…
Arrayit reports $10,000 microarray technology sale to next generation proteomic leader CDI Laboratories Baltimore MD
(link: http://cdi-lab.com)
cdi-lab.com
Arrayit receives $168,000 letter of credit from top microarray technology and life science distributor in South Asia
(link: http://arrayit.com/Products/products.html)
arrayit.com/Products/produ…
Arrayit reports $11,000 microarray services sale to a leading proteomics research company located in Southwestern US
(link: http://arrayit.com/Services/services.html)
arrayit.com/Services/servi…
Arrayit reports $18,000 microarray shipping request from $62.7 billion life sciences giant Thermo Fisher NYSE:TMO
(link: https://www.thermofisher.com/us/en/home.html)
thermofisher.com/us/en/home.html
Arrayit reports $24,000 microarray services sale to a top laboratory specializing in wellness and proteomic research
(link: http://arrayit.com/Services/services.html)
arrayit.com/Services/servi…
Arrayit reports $16,900 microarray technology sale to a top immunology research laboratory in the Southwestern USA
(link: http://arrayit.com/Services/services.html)
arrayit.com/Services/servi…
Arrayit reports $21,400 services sale to a top proteomic research laboratory in the central United States
(link: http://arrayit.com/Services/services.html)
arrayit.com/Services/servi…
Arrayit reports $7,500 microarray technology sale to global antibody production leaders Abnova Corporation in Taiwan
(link: http://www.abnova.com)
abnova.com
Arrayit reports $33,500 microarray instrument inquiry from top leaders Institute for Basic Science Ulsan South Korea
(link: http://softmatt.ibs.re.kr/html/00_main/main.php)
softmatt.ibs.re.kr/html/00_main/m…
Arrayit reports $18,000 microarray shipping request from $62.7 billion life sciences giant Thermo Fisher NYSE:TMO
(link: https://www.thermofisher.com/us/en/home.html)
thermofisher.com/us/en/home.html
Arrayit reports microarray technology sale to top leading life sciences distributor European Biotech Network Belgium
(link: http://www.euro-bio-net.com)
euro-bio-net.com
Arrayit reports $10,000 microarray services sale to leading US-based laboratory specializing in wellness research
(link: http://arrayit.com/Services/services.html)
arrayit.com/Services/servi…
Arrayit reports $30,800 microarray services sale to a top research laboratory focusing on human protein networks (link: http://arrayit.com/Services/services.html) arrayit.com/Services/servi
Arrayit reports $7,600 microarray services sale to a leading research laboratory specializing in gene expression (link: http://arrayit.com/Services/services.html) arrayit.com/Services/servi…
Arrayit reports $75,800 microarray services sale to a leading research laboratory focusing on protein networks (link: http://arrayit.com/Services/services.html) arrayit.com/Services/servi…
Arrayit reports $10,600 microarray technology sale to US-based research laboratory specializing in human proteomics (link: http://arrayit.com/Products/products.html) arrayit.com/Products/produ…
Arrayit reports $110,000 microarray instrument inquiry from services leaders AlphaMetrix Biotech Roedermark Germany (link: http://www.alphametrix.de) alphametrix.de
8.
Arrayit receives new financing lead that could generate 6,000 x $100K = $600MM in Arrayit microarray platform sales http://arrayit.com
Arrayit signs 3-year $24.4 million patented microarray technology sales and marketing agreement with a leading laboratory services provider.
ARYC also owns 40 million shares of AVDX. A value of ~$12 million
Arrayit and USDA Expanding Patent Protection for Food Safety Testing Worldwide http://www.arrayit.com/Arrayit_Corporation_ARYC_Corpo/Microarray_Media_-_Press/Arrayit_and_USDA_Expanding_Pat/arrayit_and_usda_expanding_patent_protection_for_food_safety_tes.html
Arrayit reports $400,000 microarray services inquiry from advanced pharmaceutical leader Cellceutix CTIX Beverly MA
(link: http://www.cellceutix.com)
cellceutix.com
Arrayit reports $75,800 microarray services sale to a leading research laboratory focusing on protein networks
(link: http://arrayit.com/Services/services.html)
arrayit.com/Services/servi…
Arrayit Corporation (ARYC) technology empowered scientists at the Scripps Institute to make an important medical breakthrough in diagnosing Alzheimer’s Disease. Scripps scientists used a scientific instrument known as an Arrayit NanoPrint Enterprise Level Microarrayer (shown here) to manufacture diagnostic microarray devices, which allowed researchers to identify unique protein biomarkers in the bloodstream of Alzheimer’s patients. This diagnostic test may help doctors better understand and treat the effects of this debilitating neurodegenerative disease.
Arrayit Corporation Debuts Major New Genomics and Proteomics Products in 2015/2016 Catalog
Arrayit Corporation and Vivos Team Up on Global Genome Vault
Arrayit customers in Tel Aviv Israel use Arrayit microarray technology to publish bioprosthetic heart valve advance http://onlinelibrary.wiley.com/doi/10.1111/xen.12260/full
Arrayit customers at Chemical Engineering Korea use Arrayit microarray platform to publish cholera detection advance
Arrayit reports microarray technology inquiry from next generation sequencing leader Direct Genomics Guangdong China
Arrayit selected for the 2016 Best of Sunnyvale Awards for a Biotechnology Company by Sunnyvale Business Recognition
Arrayit reports microarray technology sale to $233.2MM life sciences leader Fluidigm Nasdaq:FLDM Markham ON Canada
Arrayit reports microarray tech inquiry from $56.7B pharmaceutical giant Abbott Laboratories NYSE:ABT Carlsbad CA
Arrayit reports microarray technology sale to $56.6B life sciences juggernaut Thermo Fisher NYSE:TMO Pittsburgh PA
Arrayit reports microarray technology inquiry from top RNA hybridization leaders Advanced Cell Diagnostics Newark CA
Arrayit reports microarray reagents sale to advanced molecular diagnostics distributor AH Diagnostics Aarhus Arrayit reports microarray technology sale to top EU life sciences distributor Novusci Bedfordshire United Kingdom
Arrayit quotes $7.1 million variation identification platform (VIP) genotyping package to top clinical testing laboratory in Southeast Asia
Arrayit reports $393,294 sales and marketing lead from a top wellness and clinical testing company in European Union
Arrayit reports $7,500 microarray technology sale to top research scientists Oklahoma State University Stillwater OK
Arrayit's microarray manufacturing technology enables these new molecular diagnostic devices
Arrayit reports $20,000 specialty chemical sale to 100% owned chemical trading subsidiary TeleChem International Inc http://www.telecheminternational.com
Arrayit receives $168,000 letter of credit from top microarray technology and life science distributor in South Asia
(link: http://arrayit.com/Products/products.html)
arrayit.com/Products/produ…
Arrayit customers from Arizona State use Arrayit microarray technology to publish adult stem cell therapy advance http://www.sciencedirect.com/science/article/pii/S1873506115000598
Can an antibody microarray made with Arrayit technology replace in-situ hybs in HER2 breast cancer diagnostics?...
Arrayit reports $15K microarray sale to top medical Stephenson Cancer Center Oklahoma City http://stephensoncancercenter.org
Arrayit quotes $179,430 microarrays to biomedical leader Progenie Molecular Valencia España http://www.progenie-molecular.com
Arrayit quotes $51,680 microarrays to top leader De La Salle University Manila Philippines http://www.dlsu.edu.ph
Arrayit quotes $102,240 microarray platform to venture think tank Leading Technology Group http://www.leadingtechnology.co
Arrayit quotes $38,485 microarray platform to top Korean distributor Daemyung Science Seoul http://www.dm4you.com
Arrayit completes conference call on huge DNA testing opportunity in massive market in India http://arrayit.com/Services/SNP_Genotyping/snp_genotyping.html
Arrayit reports DNA testing inquiry from top agency in India. Market penetration of 0.1% would produce $48M revenues http://arrayit.com/Services/SNP_Genotyping/snp_genotyping.html
Arrayit quotes $235,000 microarray instruments to top lab University Ottawa Ontario Canada http://www.uottawa.ca
Arrayit reports microarray sale to advanced technology leaders Waki Company Tokyo Japan http://waki-bg.jp
Arrayit reports microarray sale to automated molecular testing leader AutoGenomics Vista CA http://www.autogenomics.com
Arrayit reports microarray sale to life sciences European Biotech Network Dolembreux Belgium http://www.euro-bio-net.com
Arrayit reports microarray sale to top medical researcher at $13.4B endowed MIT Cambridge MA http://web.mit.edu
Arrayit expands marketing on $100K+ TissueMax™ Automated and Personal Tissue Microarrayers
Arrayit reports $400,000 microarray instruments inquiry from top European Union distributor
Arrayit invited to appear on Business Television BTV hosted by broadcast partner Bloomberg http://www.b-tv.com
Arrayit $17.7MM OvaDx® spin-off and 6,000 diagnostic test pipeline possibility emphasizes the $17.7MM x 6,000 = $106B ARYC market potential.
Arrayit reports $9K chemical sale in specialty trading subsidiary TeleChem International Inc http://www.telecheminternational.com
Arrayit reports $100K microarray inquiry Al Rayyan International Science Center Amman Jordan
Arrayit products featured in 5,000+ scientific publications. https://scholar.google.com/scholar?hl=en&lr=&q=arrayit+microarray
Investors - Celebrity Spokesperson - Khrystyne Haje
Link to their products: http://www.arrayit.com/Products/products.html
https://twitter.com/arrayit
Facebook https://www.facebook.com/Arrayit
Yahoo http://finance.yahoo.com/quote/ARYC?ltr=1
http://arrayit.blogspot.com/
Sure Trader - $4.95 Per-Trade + 6:1 Leverage
iHub NewsWire
ON4 COMMUNICATIONS TO EXPAND SALES FORCE FROM 4 TO 20 AND ADDS FLY COMMUNICTCIONS INC TO HANDLE UPCOMING(ONCI) Sep 20, 2017 1:19 PM
32,000 More Square Feet Of Cannabis Grow Space
Building a strong base here over the past couple of weeks, but honestly, and we all know, this base should be much, much higher. Congrats again on your loading here :)
You not getting my shares.
Full contact, if The float is 1,033,788,804 try to buy them!!!!!
Great video:---ANY ONE SHOULD WATCH
Wow even on the weekend this board doesn't sleep.
Money never sleeps! And ARYC is MONEY!!!!